iRhythm Technologies, Inc. (IRTC)

Frontier Capital Management Co. LLC trimmed its holdings in iRhythm Technologies (NASDAQ: IRTC) by 52.7% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 106,415 shares of the company's stock after selling 118,495 shares during the period. Frontier Capital Management

Federated Hermes Inc. acquired a new position in shares of iRhythm Technologies (NASDAQ: IRTC) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 48,424 shares of the company's stock, valued at approximately $7,455,000. Federated Hermes Inc. owned approximately 0.15% of iRhythm Technologies as

iRhythm Technologies (NASDAQ: IRTC - Get Free Report) and Inspire Medical Systems (NYSE: INSP - Get Free Report) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, analyst recommendations and risk. Profitability This table compares iRhythm Technologies

Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK , Dec. 5, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to shareholders.

Shares of iRhythm Technologies (NASDAQ: IRTC - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the fifteen research firms that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation, eleven have assigned a buy recommendation and one

iRhythm Technologies, Inc. (IRTC) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of  iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to shareholders.

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.   NEW YORK , Nov. 30, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to shareholders.

NEW YORK , Nov. 17, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC)  breached their fiduciary duties to shareholders.  According to a federal securities lawsuit, Insiders at iRhythm caused the company to misrepresent or fail to disclose that the Zio AT monitor was a real-time monitor intended for high-risk patients.

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of iRhythm Technologies, Inc. (NASDAQ: IRTC). If you currently own shares of iRhythm stock, please visit the firm's website at https://rosenlegal.com/submit-form/?case_id=22399 for more information. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at case@rosenlegal.com. Why Rosen.

New York, New York--(Newsfile Corp. - November 12, 2025) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at iRhythm caused the company to misrepresent or fail to disclose that the Zio AT monitor was a real-time monitor intended for high-risk patients.

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of iRhythm Technologies, Inc. (NASDAQ: IRTC). If you currently own shares of Semtech Corporation stock, please visit the firm's website at https://rosenlegal.com/submit-form/?case_id=22399 for more information. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at case@rosenlegal.co.

New Heart Rhythm Journal publication and AHA 2025 data reinforce Zio LTCM clinical value and real-world evidence supporting proactive cardiac monitoring.

iRhythm Technologies stock has doubled this year.

SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its management team is scheduled to present at the following investor conferences.

Oppenheimer Asset Management Inc. reduced its position in iRhythm Technologies (NASDAQ: IRTC) by 40.2% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,386 shares of the company's stock after selling 1,603 shares during the period. Oppenheimer Asset